Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review

The four-component meningococcal serogroup B vaccine (4CMenB) is indicated for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup B. Co-administering 4CMenB with other vaccines may improve vaccine uptake provided that the safety and immunogenicity of ei...

Descripción completa

Detalles Bibliográficos
Autores principales: Abitbol, Véronique, Sohn, Woo-Yun, Horn, Michael, Safadi, Marco Aurelio P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Meningococcal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467517/
https://www.ncbi.nlm.nih.gov/pubmed/37642229
http://dx.doi.org/10.1080/21645515.2023.2245705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467517/
https://www.ncbi.nlm.nih.gov/pubmed/37642229
http://dx.doi.org/10.1080/21645515.2023.2245705

Ejemplares similares